Ken Yamada to Genetic Therapy
This is a "connection" page, showing publications Ken Yamada has written about Genetic Therapy.
Connection Strength
0.069
-
Xicluna R, Yamada K, Gonzalez-Visiedos M, Greenwood CM, Zaugg D, Waiz D, Steiner G, Hahn K, Schwandt T, Otteneder MB, Biswas M, Mu?oz-Melero M, Kumar SRP, Herzog RW, Haegel H. Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer. Mol Ther. 2026 Jul 01; 34(7):3805-3819.
Score: 0.036
-
Furusho T, Das R, Hakui H, Sairavi A, Adachi K, Galbraith-Liss MS, Rajagopal P, Horikawa M, Luo S, Li L, Yamada K, Andeen N, Dissen GA, Nakai H. Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids. Nat Commun. 2024 12 30; 15(1):10728.
Score: 0.033